Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15850)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2017 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cayzeele-Decherf A, Pélerin F, Leuillet S, Douillard B, Housez B, Cazaubiel M, Jacobson GK, Jüsten P, Desreumaux P. Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. World J Gastroenterol 2017; 23(2): 336-344 [PMID: 28127207 DOI: 10.3748/wjg.v23.i2.336] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i2/336.htm |
| Number | Citing Articles |
| 1 |
Jordan Shapiro, Jessica Bernica, Ruben Hernaez. Risk of Bias Analysis of Systematic Reviews of Probiotics for Treatment of Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology 2019; 17(4): 784 doi: 10.1016/j.cgh.2018.07.010
|
| 2 |
Maura Di Vito, Maria Grazia Bellardi, Maurizio Sanguinetti, Francesca Mondello, Antonietta Girolamo, Lorenzo Barbanti, Stefania Garzoli, Manuela Sabatino, Rino Ragno, Alberto Vitali, Ivana Palucci, Brunella Posteraro, Antonio Gasbarrini, Gian Maria Prati, Giovanni Aragona, Paola Mattarelli, Francesca Bugli. Potent In Vitro Activity of Citrus aurantium Essential Oil and Vitis vinifera Hydrolate Against Gut Yeast Isolates from Irritable Bowel Syndrome Patients—The Right Mix for Potential Therapeutic Use. Nutrients 2020; 12(5): 1329 doi: 10.3390/nu12051329
|
| 3 |
Soo Liang Ooi, Dianne Correa, Sok Cheon Pak. Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome – What is the current evidence?. Complementary Therapies in Medicine 2019; 43: 73 doi: 10.1016/j.ctim.2019.01.010
|
| 4 |
A. P. S. Hungin, C. R. Mitchell, P. Whorwell, C. Mulligan, O. Cole, L. Agréus, P. Fracasso, C. Lionis, J. Mendive, J.‐M. Philippart de Foy, B. Seifert, K.‐A. Wensaas, C. Winchester, N. de Wit. Systematic review: probiotics in the management of lower gastrointestinal symptoms – an updated evidence‐based international consensus. Alimentary Pharmacology & Therapeutics 2018; 47(8): 1054 doi: 10.1111/apt.14539
|
| 5 |
Industrially Important Fungi for Sustainable Development. Fungal Biology 2021; : 393 doi: 10.1007/978-3-030-67561-5_12
|
| 6 |
Lynne V. McFarland, Tarkan Karakan, Ali Karatas. Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. eClinicalMedicine 2021; 41: 101154 doi: 10.1016/j.eclinm.2021.101154
|
| 7 |
Michael Camilleri. Management Options for Irritable Bowel Syndrome. Mayo Clinic Proceedings 2018; 93(12): 1858 doi: 10.1016/j.mayocp.2018.04.032
|
| 8 |
Thuy-Linh Nguyen, Mingzhan Toh, Yuyun Lu, Sebastian Ku, Shao-Quan Liu. Biovalorization of Market Surplus Bread for Development of Probiotic-Fermented Potential Functional Beverages. Foods 2022; 11(3): 250 doi: 10.3390/foods11030250
|
| 9 |
Francisco Guarner, Mary Ellen Sanders, Hania Szajewska, Henry Cohen, Rami Eliakim, Claudia Herrera-deGuise, Tarkan Karakan, Dan Merenstein, Alejandro Piscoya, Balakrishnan Ramakrishna, Seppo Salminen, Jim Melberg. World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics. Journal of Clinical Gastroenterology 2024; 58(6): 533 doi: 10.1097/MCG.0000000000002002
|
| 10 |
Emily M. Mercer, Marie-Claire Arrieta. Probiotics to improve the gut microbiome in premature infants: are we there yet?. Gut Microbes 2023; 15(1) doi: 10.1080/19490976.2023.2201160
|
| 11 |
Lucinda A. Harris, Noemi Baffy. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Postgraduate Medicine 2017; 129(8): 872 doi: 10.1080/00325481.2017.1383819
|
| 12 |
Florian Mourey, Amélie Decherf, Jean-François Jeanne, Mathieu Clément-Ziza, Marie-Lise Grisoni, François Machuron, Sophie Legrain-Raspaud, Arnaud Bourreille, Pierre Desreumaux. <i>Saccharomyces cerevisiae </i>I-3856 in irritable bowel syndrome with predominant constipation. World Journal of Gastroenterology 2022; 28(22): 2509-2522 doi: 10.3748/wjg.v28.i22.2509
|
| 13 |
Efstathia I. Paramera, Vaios T. Karathanos, Spyros J. Konteles. Microencapsulation in the Food Industry. 2023; : 343 doi: 10.1016/B978-0-12-821683-5.00002-9
|
| 14 |
Mehvish Habib, Iqra Qureshi, Kulsum Jan, Khalid Bashir. Functional Foods and Nutraceuticals: Chemistry, Health Benefits and the Way Forward. 2024; : 199 doi: 10.1007/978-3-031-59365-9_9
|
| 15 |
Nathalie Ballet, Sarah Renaud, Hugo Roume, Fanny George, Pascal Vandekerckove, Mickaël Boyer, Mickaël Durand-Dubief. Saccharomyces cerevisiae: Multifaceted Applications in One Health and the Achievement of Sustainable Development Goals. Encyclopedia 2023; 3(2): 602 doi: 10.3390/encyclopedia3020043
|
| 16 |
Advances in Probiotics for Sustainable Food and Medicine. Microorganisms for Sustainability 2021; 21: 181 doi: 10.1007/978-981-15-6795-7_8
|
| 17 |
Asim K. Duttaroy. Evidence-Based Nutrition and Clinical Evidence of Bioactive Foods in Human Health and Disease. 2021; : 269 doi: 10.1016/B978-0-12-822405-2.00006-2
|
| 18 |
UegWeek 2020 Poster Presentations. United European Gastroenterology Journal 2020; 8(S8): 144 doi: 10.1177/2050640620927345
|
| 19 |
Maria Napolitano, Ernesto Fasulo, Federica Ungaro, Luca Massimino, Emanuele Sinagra, Silvio Danese, Francesco Vito Mandarino. Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications. Microorganisms 2023; 11(10): 2369 doi: 10.3390/microorganisms11102369
|
| 20 |
Ao Liu, Wenkang Gao, Yixin Zhu, Xiaohua Hou, Huikuan Chu. Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome. Toxins 2022; 14(9): 596 doi: 10.3390/toxins14090596
|
| 21 |
Natalie Ramsy, Sonia Michail. Encyclopedia of Gastroenterology. 2020; : 289 doi: 10.1016/B978-0-12-801238-3.66050-6
|
| 22 |
C. Roussel, A. Sivignon, A. de Vallée, G. Garrait, S. Denis, V. Tsilia, N. Ballet, P. Vandekerckove, T. Van de Wiele, N. Barnich, S. Blanquet-Diot. Anti-infectious properties of the probiotic Saccharomyces cerevisiae CNCM I-3856 on enterotoxigenic E. coli (ETEC) strain H10407. Applied Microbiology and Biotechnology 2018; 102(14): 6175 doi: 10.1007/s00253-018-9053-y
|
| 23 |
Angel de la Cruz Pech-Canul, David Ortega, Antonio García-Triana, Napoleón González-Silva, Rosa Lidia Solis-Oviedo. A Brief Review of Edible Coating Materials for the Microencapsulation of Probiotics. Coatings 2020; 10(3): 197 doi: 10.3390/coatings10030197
|
| 24 |
Nobuo Fuke, Koichi Aizawa, Hiroyuki Suganuma, Tomohisa Takagi, Yuji Naito. Effect of combined consumption ofLactobacillus brevisKB290 andβ-carotene on minor diarrhoea-predominant irritable bowel syndrome-like symptoms in healthy subjects: a randomised, double-blind, placebo-controlled, parallel-group trial. International Journal of Food Sciences and Nutrition 2017; 68(8): 973 doi: 10.1080/09637486.2017.1311843
|
| 25 |
Eve W.L. Chow, Li Mei Pang, Yue Wang. Impact of the host microbiota on fungal infections: New possibilities for intervention?. Advanced Drug Delivery Reviews 2023; 198: 114896 doi: 10.1016/j.addr.2023.114896
|
| 26 |
Caroline Valibouze, Silvia Speca, Caroline Dubuquoy, Florian Mourey, Lena M'Ba, Lucil Schneider, Marie Titecat, Benoît Foligné, Michaël Genin, Christel Neut, Philippe Zerbib, Pierre Desreumaux. <i>Saccharomyces cerevisiae</i> prevents postoperative recurrence of Crohn's disease modeled by ileocecal resection in HLA-B27 transgenic rats. World Journal of Gastroenterology 2023; 29(5): 851-866 doi: 10.3748/wjg.v29.i5.851
|
| 27 |
Adelina Nicoleta Galica, Reitano Galica, Dan Lucian Dumitrașcu. Diet, fibers, and probiotics for irritable bowel syndrome. Journal of Medicine and Life 2022; 15(2): 174 doi: 10.25122/jml-2022-0028
|
| 28 |
E. Gabrielli, E. Pericolini, N. Ballet, E. Roselletti, S. Sabbatini, P. Mosci, A. Cayzeele Decherf, F. Pélerin, S. Perito, P. Jüsten, A. Vecchiarelli. Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis. Beneficial Microbes 2018; 9(2): 219 doi: 10.3920/BM2017.0099
|
| 29 |
Ravichandran Gayathri, Thangavelu Aruna, Sivaraman Malar, Bennur Shilpa, Karukkupalayam Ramasamy Dhanasekar. Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an add-on therapy for irritable bowel syndrome. International Journal of Colorectal Disease 2020; 35(1): 139 doi: 10.1007/s00384-019-03462-4
|
| 30 |
Charles C. Herndon, Yen‐Po Wang, Ching‐Liang Lu. Targeting the gut microbiota for the treatment of irritable bowel syndrome. The Kaohsiung Journal of Medical Sciences 2020; 36(3): 160 doi: 10.1002/kjm2.12154
|
| 31 |
Legaki Evangelia, Eleni Anna Karanasou, Maria Gazouli. Gut Microbiome-Related Diseases and Therapies. The Microbiomes of Humans, Animals, Plants, and the Environment 2021; 1: 41 doi: 10.1007/978-3-030-59642-2_3
|
| 32 |
Olivia Mondal, Devanshi Khanna, Shalja Panwar, Shilpa Negi, Sneha Basu. Systematic Review on Therapeutic Applications of Yeast 'Saccharomyces'. International Journal of Scientific Research in Science and Technology 2021; : 174 doi: 10.32628/IJSRST218226
|
| 33 |
Vivian Tullio. Probiotic Yeasts: A Developing Reality?. Journal of Fungi 2024; 10(7): 489 doi: 10.3390/jof10070489
|
| 34 |
Moghaddaseh Jahanshahi, Parisa Maleki Dana, Bita Badehnoosh, Zatollah Asemi, Jamal Hallajzadeh, Mohammad Ali Mansournia, Bahman Yousefi, Bahram Moazzami, Shahla Chaichian. Anti-tumor activities of probiotics in cervical cancer. Journal of Ovarian Research 2020; 13(1) doi: 10.1186/s13048-020-00668-x
|
| 35 |
Sadegh Sulaimany, Kajal Farahmandi, Aso Mafakheri. Computational prediction of new therapeutic effects of probiotics. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62796-4
|
| 36 |
Bruno K. Rodiño-Janeiro, María Vicario, Carmen Alonso-Cotoner, Roberto Pascua-García, Javier Santos. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Advances in Therapy 2018; 35(3): 289 doi: 10.1007/s12325-018-0673-5
|
| 37 |
Kajal Farahmandi, Sadegh Sulaimany. Advances in Probiotics for Health and Nutrition. 2024; doi: 10.5772/intechopen.109717
|
| 38 |
Eirini Dimidi, Megan Rossi, Kevin Whelan. Irritable bowel syndrome and diet. Current Opinion in Clinical Nutrition & Metabolic Care 2017; 20(6): 456 doi: 10.1097/MCO.0000000000000416
|
| 39 |
Yuying Liu, Dat Q. Tran, J. Marc Rhoads. Probiotics in Disease Prevention and Treatment. The Journal of Clinical Pharmacology 2018; 58(S10) doi: 10.1002/jcph.1121
|
| 40 |
Roberta Gaziano, Samuele Sabbatini, Elena Roselletti, Stefano Perito, Claudia Monari. Saccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.00718
|
| 41 |
Rajnish Prakash Singh, Afreen Shadan, Ying Ma. Biotechnological Applications of Probiotics: A Multifarious Weapon to Disease and Metabolic Abnormality. Probiotics and Antimicrobial Proteins 2022; 14(6): 1184 doi: 10.1007/s12602-022-09992-8
|
| 42 |
P. Layer, V. Andresen, H. Allescher, S. C. Bischoff, M. Claßen, S. Elsenbruch, M. Freitag, T. Frieling, M. Gebhard, M. Goebel-Stengel, W. Häuser, G. Holtmann, J. Keller, M. E. Kreis, W. Kruis, J. Langhorst, P. Lynen Jansen, A. Madisch, H. Mönnikes, S. Müller-Lissner, B. Niesler, C. Pehl, D. Pohl, M. Raithel, G. Röhrig-Herzog, M. Schemann, S. Schmiedel, J. Schwille-Kiuntke, M. Storr, J. C. Preiß, T. Andus, S. Buderus, U. Ehlert, M. Engel, A. Enninger, W. Fischbach, A. Gillessen, J. Gschossmann, F. Gundling, S. Haag, U. Helwig, S. Hollerbach, M. Karaus, M. Katschinski, H. Krammer, R. Kuhlbusch-Zicklam, H. Matthes, D. Menge, S. Miehlke, M. C. Posovszky, R. Schaefert, A. Schmidt-Choudhury, O. Schwandner, A. Schweinlin, H. Seidl, A. Stengel, J. Tesarz, I. van der Voort, W. Voderholzer, G. von Boyen, J. von Schönfeld, T. Wedel. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Zeitschrift für Gastroenterologie 2021; 59(12): 1323 doi: 10.1055/a-1591-4794
|
| 43 |
Lynne Vernice McFarland, Tarkan Karatas, Ali Karatas. Strain-Specific and Outcome-Specific Efficacy of Probiotics for the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3894914
|
| 44 |
Amelie Decherf, Elodie Dehay, Mickaël Boyer, Mathieu Clément-Ziza, Bertrand Rodriguez, Sophie Legrain-Raspaud. Recovery of Saccharomyces cerevisiae CNCM I-3856 in Vaginal Samples of Healthy Women after Oral Administration. Nutrients 2020; 12(8): 2211 doi: 10.3390/nu12082211
|
| 45 |
Isabel Marie Grambusch, Caroline Schmitz, Cláudia Schlabitz, Rodrigo Gay Ducati, Daniel Neutzling Lehn, Claucia Fernanda Volken de Souza. Encapsulation of Saccharomyces spp. for Use as Probiotic in Food and Feed: Systematic Review and Meta-analysis. Probiotics and Antimicrobial Proteins 2024; 16(6): 1979 doi: 10.1007/s12602-024-10331-2
|
| 46 |
Pablo Roman, Raquel Abalo, Eva M. Marco, Diana Cardona. Probiotics in digestive, emotional, and pain-related disorders. Behavioural Pharmacology 2018; 29(2 and 3): 103 doi: 10.1097/FBP.0000000000000385
|